HK1151242A1 - 肽組合物及使用方法 - Google Patents
肽組合物及使用方法Info
- Publication number
- HK1151242A1 HK1151242A1 HK11105411.7A HK11105411A HK1151242A1 HK 1151242 A1 HK1151242 A1 HK 1151242A1 HK 11105411 A HK11105411 A HK 11105411A HK 1151242 A1 HK1151242 A1 HK 1151242A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- mntf
- methods
- peptide compositions
- compositions
- mntf peptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6666908P | 2008-02-21 | 2008-02-21 | |
PCT/US2009/034923 WO2009105780A2 (en) | 2008-02-21 | 2009-02-23 | Mntf peptide compositions and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1151242A1 true HK1151242A1 (zh) | 2012-01-27 |
Family
ID=40792684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK11105411.7A HK1151242A1 (zh) | 2008-02-21 | 2011-05-31 | 肽組合物及使用方法 |
Country Status (10)
Country | Link |
---|---|
US (1) | US8846615B2 (zh) |
EP (1) | EP2247300B1 (zh) |
JP (1) | JP5718649B2 (zh) |
CN (1) | CN101951942B (zh) |
AU (1) | AU2009217266B2 (zh) |
CA (1) | CA2716392C (zh) |
DK (1) | DK2247300T3 (zh) |
ES (1) | ES2569552T3 (zh) |
HK (1) | HK1151242A1 (zh) |
WO (1) | WO2009105780A2 (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2247300T3 (en) | 2008-02-21 | 2016-05-09 | Genervon Biopharmaceuticals Llc | Mntf peptide compositions and methods of use thereof |
TWI565712B (zh) | 2014-10-20 | 2017-01-11 | 福又達生物科技股份有限公司 | 增進神經元生長的胜肽及其應用 |
WO2016210123A1 (en) | 2015-06-26 | 2016-12-29 | Genervon Biopharmaceuticals, LLC | Methods of using gm604 in modulating als disease biomarkers leading to prognosis and therapeutic treatment for als disease |
CN111925411B (zh) * | 2017-06-29 | 2022-04-08 | 安徽省农业科学院农产品加工研究所 | 一种含有Cys-Ser的高锌螯合活性锌螯合肽及其应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69740051D1 (de) * | 1996-09-27 | 2010-12-23 | Genervon Biopharmaceuticals Llc | Isolierung und verwendung motoneuronotrophischer faktoren |
US6309877B1 (en) * | 1996-09-27 | 2001-10-30 | Km Biotech, Inc. | Polynucleotides encoding motoneuronotrophic factors |
US6841531B2 (en) * | 1996-09-27 | 2005-01-11 | Genervon Biopharmaceuticals Llc | Methods and use of motoneuronotrophic factors |
DK1587526T3 (da) * | 2003-01-21 | 2012-02-06 | Genervon Biopharmaceuticals Llc | MNTF-peptider og sammensætninger og anvendelsesmåder |
JP5270362B2 (ja) * | 2005-11-10 | 2013-08-21 | ジェナボン バイオファーマシューティカルズ エルエルシー | 幹細胞のmntf分化および成長 |
US20100028916A1 (en) * | 2006-06-09 | 2010-02-04 | Bio Pur Ag | Method for the detection of enzymatic reactions |
WO2008057609A2 (en) * | 2006-11-10 | 2008-05-15 | Genervon Biopharmaceuticals Llc | Methods of treating neuronal disorders using mntf peptides and analogs thereof |
DK2247300T3 (en) | 2008-02-21 | 2016-05-09 | Genervon Biopharmaceuticals Llc | Mntf peptide compositions and methods of use thereof |
EP2247613B1 (en) * | 2008-02-21 | 2018-05-30 | Dermacare Neuroscience Institute | Cosmetic and dermatological formulations of mntf peptides |
-
2009
- 2009-02-23 DK DK09712319.4T patent/DK2247300T3/en active
- 2009-02-23 CN CN200980105892.9A patent/CN101951942B/zh not_active Expired - Fee Related
- 2009-02-23 JP JP2010547846A patent/JP5718649B2/ja not_active Expired - Fee Related
- 2009-02-23 EP EP09712319.4A patent/EP2247300B1/en not_active Not-in-force
- 2009-02-23 AU AU2009217266A patent/AU2009217266B2/en not_active Ceased
- 2009-02-23 ES ES09712319.4T patent/ES2569552T3/es active Active
- 2009-02-23 WO PCT/US2009/034923 patent/WO2009105780A2/en active Application Filing
- 2009-02-23 US US12/391,234 patent/US8846615B2/en active Active
- 2009-02-23 CA CA2716392A patent/CA2716392C/en active Active
-
2011
- 2011-05-31 HK HK11105411.7A patent/HK1151242A1/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2009217266B2 (en) | 2014-10-16 |
DK2247300T3 (en) | 2016-05-09 |
JP5718649B2 (ja) | 2015-05-13 |
CA2716392C (en) | 2019-05-21 |
CN101951942A (zh) | 2011-01-19 |
WO2009105780A2 (en) | 2009-08-27 |
EP2247300A2 (en) | 2010-11-10 |
JP2011513239A (ja) | 2011-04-28 |
WO2009105780A3 (en) | 2009-11-05 |
CA2716392A1 (en) | 2009-08-27 |
US8846615B2 (en) | 2014-09-30 |
EP2247300B1 (en) | 2016-04-13 |
US20090286747A1 (en) | 2009-11-19 |
ES2569552T3 (es) | 2016-05-11 |
AU2009217266A1 (en) | 2009-08-27 |
CN101951942B (zh) | 2014-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL245172A0 (en) | Pharmaceutical preparations and methods for transferring them related to them | |
HRP20160902T1 (hr) | Pripravci i postupci uporabe forbolskih estera | |
IL209136A0 (en) | Compositions of peptides and processes of preparation thereof | |
EP2364161A4 (en) | COMPOSITIONS CONTAINING SATIOGENES AND METHODS OF USE | |
EP2373679A4 (en) | HEPPIDINE MINI PEPTIDES AND METHODS OF USE | |
EP2334185A4 (en) | COMPOSITIONS AND METHODS FOR USE OF (R) -PRAMIPEXOL | |
IL208946A0 (en) | Immunomodulating compositions and methods of use thereof | |
PT2320911E (pt) | Composições de vasoconstrição e métodos de utilização | |
HK1144823A1 (zh) | 前胰島肽和其類似物的成份和使用方法 | |
EP2231665A4 (en) | NEW COMPOSITIONS AND METHODS OF USE | |
HRP20181380T1 (hr) | Lipopeptidne kompozicije i s njima povezani postupci | |
EP2403935A4 (en) | COMPOSITIONS COMPRISING ANGIOGENIC FACTORS AND METHODS OF USE | |
EP2506709A4 (en) | AMANTADIN COMPOSITIONS AND METHODS OF USE THEREOF | |
EP2346521A4 (en) | PEPTIDES AND METHODS OF USE | |
EP2376101A4 (en) | ARRESTIN EFFECTORS AND COMPOSITIONS AND METHOD OF APPLICATION THEREFOR | |
HK1151438A1 (zh) | 氣體瀉流組合物以及製造和使用其的方法 | |
GB0812890D0 (en) | Compositions and methods of making compositions | |
ZA201102207B (en) | Cinnamandehyde-allicin compositions and their method of use | |
IL207827A0 (en) | Apoaequorin-containing compositions and methods of using same | |
HK1151242A1 (zh) | 肽組合物及使用方法 | |
ZA201004894B (en) | Nuctraceutical composition and methods of use | |
HK1166953A1 (zh) | 組合物及使用方法 | |
ZA201004893B (en) | Nuctraceutical composition and methods of use | |
PL2128112T3 (pl) | Cząsteczkowe kompozycje odpowietrzające i sposoby ich stosowania | |
GB0820804D0 (en) | Perinropril composition and method of use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20210223 |